ISRCTN18642314已完成未知
Impact of a novel molecular tuberculosis (TB) diagnostic system in patients at high risk of TB mortality in rural South Africa: a pragmatic cluster randomised controlled trial
ondon School of Hygiene and Tropical Medicine (UK)0 个研究点目标入组 2,000 人开始时间: 2011年6月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. TB suspect (defined as cough of any duration)
- •2. Age 18 years or older
- •3. Confirmed human immunodeficiency virus (HIV) infection and/or high risk for multi-drug-resistant tuberculosis (MDR-TB)
排除标准
- •1. Severely unwell requiring admission to hospital
- •2. Previous MDR/extensively drug-resistant tuberculosis (XDR-TB) diagnosis or treatment
- •3. Diagnosis or suspicion of extra-pulmonary TB only
- •4. Unable to give informed consent
研究者
相似试验
招募中
不适用
GeneXpert Demonstration Study MTB/RIFTuberculosisPACTR201010000255244niversity of Cape Town1,700
已完成
不适用
ISAAC 004TuberculosisPACTR201402000765312.S. National Institutes of Health120
已完成
不适用
A phase I study evaluating the safety and immunogenicity of a new tuberculosis (TB) vaccine, MVA85A, in healthy volunteers who are infected with human immunodeficiency virus (HIV)Human immunodeficiency virus (HIV), tuberculosis (TB)Infections and InfestationsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesISRCTN34189114niversity of Oxford (UK)20
Enrolling By Invitation
不适用
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis InfectionLatent Tuberculosis InfectionTuberculosis Infection, LatentNCT06728930Queen Mary University of London250
已完成
不适用
A phase I study to assess the safety and immunogenicity of new tuberculosis (TB) vaccine candidates FP85A and MVA85A, in healthy adults who have previously been immunised with Bacillus Calmette-Guerin (BCG), using a prime-boost delivery scheduleTuberculosisISRCTN12385972niversity of Oxford (UK)36